INCY earnings: real EPS beat/miss history, analyst consensus Buy, P/E 15.86. Updated 2026-07-23.
Incyte (INCY) Research Hub
Incyte (INCY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 121.47 USD (-3.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 15.86, market cap 23.33B. This hub links to the full technical, earnings and options research available for INCY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 121.47 USD (-3.60%) |
| 52-week range | 98.25 USD – 132.6 USD |
| Trend regime | Range |
| 14-day RSI | 51.5 (Neutral) |
| Trailing P/E | 15.86 |
| Market cap | 23.33B |
| Dividend yield | 0.00% |
Available research for INCY
Covered Call on INCY: how it works, illustrative setup around the real 121.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INCY: how it works, illustrative setup around the real 121.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INCY: how it works, illustrative setup around the real 121.47 USD price, max profit/loss, breakeven and when to use it. Educational.
INCY technical analysis: range, last 121.47 USD, RSI 51.5, 52w range 98.25 USD–132.6 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is INCY in?
Incyte (INCY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INCY in an uptrend or downtrend?
As of 2026-09-11, INCY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INCY's trailing P/E ratio?
INCY's trailing P/E is 15.86, with a market cap of 23.33B. See the earnings research page for full valuation detail.